Thermo Fisher Scientific has entered a scientific collaboration with NIBRT for the development of analytical solutions for the characterization of complex biopharmaceuticals.The complexity of biopharmaceuticals requires advanced analytical characterization to help ensure the highest possible quality production.
 
NIBRT will develop workflows on the Thermo Scientific biomolecule column range with its associated consumable portfolio, together with Thermo Scientific’s liquid chromatography systems and  Orbitrap high-resolution mass spectrometers.
 
NIBRT’s workflows and methods will be uploaded to the Thermo Scientific AppsLab library, a cloud-based application compendium that enables scientists to access and download these analytical solutions directly to their instruments.
 
“This collaboration is important because it enables our team to access Thermo Fisher’s world leading columns and analytical instrumentation to develop total analytical solutions and streamline the characterization of complex biopharmaceuticals,” said Dr. Jonathan Bones, principal investigator, NIBRT’s Characterization and Compatibility Laboratory.  “The availability of total analytical solutions to scientists across the world is empowering and motivates us at NIBRT to continually perform excellent impactful research.”
 
“Analytical characterization of biopharmaceuticals remains a challenge for scientists and requires cutting edge chromatography solutions and mass spectrometry detection,” said Jakob Gudbrand, president of chromatography and analytical technologies at Thermo Fisher. “NIBRT is an independent center of excellence with collaborations across the major biopharmaceutical companies in the industry.  This allows them to provide valuable insights to improve the technology, simplify analysis, generate informative characterization data and understand these complex molecules.”